Reliq Health Technologies Inc (RHT)

[Sam Dan]

Management wakes up that Investor relations needs improvement
"- Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company that develops innovative mobile health (mHealth) and telemedicine solutions for the community-based healthcare market, today announced that effective immediately, the Chief Visionary Officer Mr. Giancarlo De Lio is no longer employed by the Company.

In addition, the Company is pleased to announce that it has engaged Sophic Capital as its Investor Relations firm. Sophic Capital is a comprehensive capital markets advisory firm focused on microcap growth companies.

“These changes reflect Reliq’s commitment to improving our investor communications and to ensuring transparency, accountability and execution within the organization going forward,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies. “With healthy cash reserves, a strong customer pipeline and a powerful technology platform, the Company looks forward to continuing to work with our clients to improve health outcomes and expand access to care for chronic disease patients in the US, Canada and beyond.”

“Sophic Capital has followed Reliq’s story for a number of years, and we are excited to be working with the Company to help communicate the story to the capital markets,” said Sean Peasgood, President and CEO of Sophic Capital. “Reliq is targeting a unique market in which the constituents will likely see improved health and safety outcomes from its mHealth care solutions. We believe that Reliq is well positioned for future growth and look forward to helping the company communicate successful milestones to the capital markets in the coming quarters.”

Reliq’s engagement with Sophic Capital is a 12-month term, on a fee-for-service basis of $7,000 CAD per month. In addition, Reliq has granted Sophic 300,000 options to purchase Reliq shares at a price of $0.53 per share. The options will vest over 12 months and will expire on October 23, 2021."